Item 5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) Amendment and Restatement of Stock Option Plan.

As previously disclosed, on May 29, 2009, the Board of Directors of Anika Therapeutics, Inc. (the "Company"), approved an amendment to the Company's Amended and Restated 2003 Stock Option and Incentive Plan (the "2003 Plan") to reduce the proposed increase in the number of shares subject to the 2003 Plan from 1,000,000 to 850,000, which would result in a total of 2,350,000 shares of common stock being reserved for issuance under the 2003 Plan.

On June 5, 2009, the Company held its annual meeting of stockholders and based on the certified results, the Company's stockholders approved the 2003 Plan.

A copy of the 2003 Plan, reflecting the 2,350,000 shares of common stock reserved for issuance, is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

10.1 Anika Therapeutics, Inc. Amended and Restated 2003 Stock Option and Incentive Plan